Czech President Signs Law Limiting Medicine Re-Exports – But Will It Work?
Executive Summary
An amendment to the Medicines Act designed to limit distributors’ ability to parallel export medicines to higher priced EU markets has been signed, but some lawyers argue it might not be fit for purpose.
You may also be interested in...
EU Member States Taking New Steps To Tackle Drug Shortages
The EU Heads of Medicines Agencies has outlined some of the recent initiatives taken by the member states to deal with medicines shortages, including a new Dutch center and a member state coordinating initiative by the Irish regulator.
Parallel Traders Slam Czech Plan For List Of Non-Exportable Drugs
European parallel traders are unhappy with a Czech government proposal to draw up a list of “irreplaceable” medicines that are subject to restrictions on re-exportation.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.